Biochemical profiles and organ dysfunction in neonates with hypoxic-ischemic encephalopathy post-hoc analysis of the THIN trial.

"Declarations Ethics approval and consent to participateInformed consent was obtained from the parent(s) of all the subjects. The study was approved by the Institutional Review Board at the Christian Medical College (number 2013/8223) and the Regional Committee for Medical and Health Research Ethics in central Norway (number 2013/2167, reference: 18557). Consent for publicationNot applicable. Competing interestsNT has a patent 1796/DEL/2013 Life cradle device for inducing neonatal hypothermia issued. The other authors declare that they have no competing interests. Competing interests NT has a patent 1796/DEL/2013 Life cradle device for inducing neonatal hypothermia issued. The other authors declare that they have no competing interests."

"Funding Open access funding provided by Norwegian University of Science and Technology Funding for the THIN study was provided by Central Norway Regional Health Authority (RHA) (reference: 2017/38297) and the Norwegian University of Science and Technology (NTNU) (reference: 2014/97710). There was no additional funding for this post-hoc analysis."

"Trial registration Data from this article was collected during the THIN-study (Therapeutic Hypothermia in India; ref. CTRI/2013/05/003693 Clinical Trials Registry – India)."